Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice
- 29 February 2004
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 31 (2), 213-223
- https://doi.org/10.1016/j.nucmedbio.2003.08.004
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Pretargeted Radioimmunotherapy (PRIT™) for Treatment of Non-Hodgkin's Lymphoma (NHL): Initial Phase I/II Study ResultsCancer Biotherapy & Radiopharmaceuticals, 2000
- Avidin–biotin system for delivery of diagnostic agentsAdvanced Drug Delivery Reviews, 1999
- Development of a Streptavidin−Anti-Carcinoembryonic Antigen Antibody, Radiolabeled Biotin Pretargeting Method for Radioimmunotherapy of Colorectal Cancer. Studies in a Human Colon Cancer Xenograft ModelBioconjugate Chemistry, 1997
- Biotin Reagents for Antibody Pretargeting. Synthesis, Radioiodination, and in Vitro Evaluation of Water Soluble, Biotinidase Resistant Biotin DerivativesBioconjugate Chemistry, 1997
- In vitro and in vivo evaluation of streptavidin immunoconjugates of the second generation TAG-72 monoclonal antibody CC49Nuclear Medicine and Biology, 1995
- Expression of tag‐72 in normal colon, transitional mucosa, and colon cancerInternational Journal of Cancer, 1989
- Tumor‐associated glycoprotein (TAG‐72) detected in adenocarcinomas and benign lesions of the stomachInternational Journal of Cancer, 1986
- Use of monoclonal antibodies to human breast‐tumor‐associated antigens in fine‐needle aspirate cytologyInternational Journal of Cancer, 1986
- Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomasInternational Journal of Cancer, 1983
- A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor‐associated antigen in human mammary carcinoma cell populationsInternational Journal of Cancer, 1982